Choose Your language:
- Testimonials
-
i have recept my viagra thanks you
- robert
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole ... - MarketWatch (press release)
- PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in ... - MarketWatch (press release)
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in
- POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial Results - MarketWatch (press release)
- POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial ResultsMarketWatch (press release)POZEN announced positive top-line results from two randomized, double-blind, multi-center, pivotal Phase 3 clinical trials of PA32540, a novel, coordinated-delivery tablet of immediate-release omeprazole (40 mg) and delayed release aspirin (325 mg)
- Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with ... - 7thSpace Interactive (press release)
- Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with
- Pernix launches new therapy to eradicate H. pylori - Pharmaceutical Business Review
- Pernix launches new therapy to eradicate H
